25-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic cystoid macular edema associated with branch retinal vein occlusion

Retina

Volumn 28, Issue 7, 2008, Pages 947-956

  Ma, Jin ^a   Yao, Ke ^a   Zhang, Zheng ^a   Tang, Xiajing ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Internal limiting membrane peeling; Macular edema; Retinal vein occlusion

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERNAL LIMITING MEMBRANE; MALE; RETINA; RETINA FOVEA; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; VISUAL ACUITY; VITRECTOMY;

ADULT; AGED; BASEMENT MEMBRANE; CHRONIC DISEASE; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MACULAR EDEMA; MALE; MICROSURGERY; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITRECTOMY;

EID: 67949109587     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31816c683d     Document Type: Article

References (49)

1. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol 1986;104:34-41.
2. Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-282.
3. Miller SD. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1985;99:218-219.
4. Trempe CL, Takahashi M, Topilow HW. Vitreous changes in retinal branch vein occlusion. Ophthalmology 1981;88:681-687.
5. Kado M, Trempe CL. Role of the vitreous in branch retinal vein occlusion. Am J Ophthalmol 1988;105:20-24.
6. Avunduk AM, Cetinkaya K, Kapicioglu Z, et al. The effect of posterior vitreous detachment on the prognosis of branch retinal vein occlusion. Acta Ophthalmol Scand 1997;75:441-442.
7. Takahashi MK, Hikichi T, Akiba J, et al. Role of the vitreous and macular edema in branch retinal vein occlusion. Ophthalmic Surg Lasers 1997;28:294-299.
8. Tachi N, Hashimoto Y, Ogino N. Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol 1999;97:465-469.
9. Kurimoto M, Takagi H, Suzuma K, et al. Vitrectomy for macular edema secondary to retinal vein occlusion. Jpn J Ophthalmol 1999;53:717-720.
10. Kumagai K, Ogino N, Furukawa M, et al. Vitreous surgery for macular edema in branch retinal vein occlusion. Nippon Ganka Gakkai Zasshi 2002;106:701-707.
11. Saika S, Tanaka T, Miyamoto T, et al. Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 2001;239:729-732.
12. Radetzky S, Walter P, Fauser S, et al. Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2004;242: 273-278.
13. Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina 2004;24: 348-355.
14. Becquet F, Le Rouic JF, Zanlonghi X, et al. Efficiency of surgical treatment for chronic macular edema due to branch retinal vein occlusion. J Fr Ophtalmol 2003;26:570-576.
15. Patel JI, Hykin PG, Schadt M, et al. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 2006;26:5-13.
16. Kamura Y, Sato Y, Isomae T, et al. Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients. Jpn J Ophthalmol 2005;49:297-300.
17. Peyman GA, Canakis C, Livir-Rallatos C, et al. The effect of internal limiting membrane peeling on chronic recalcitrant pseudophakic cystoid macular edema: a report of two cases. Am J Ophthalmol 2002;133:571-572.
18. Ando F, Yasui O, Hirose H, et al. Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling. Graefes Arch Clin Exp Ophthalmol 2004;242:995-999.
19. Maia M, Haller J, Pieramici DJ, et al. Retinal pigment epithelial abnormalities after internal limiting membrane peeling guided by indocyanine green staining. Retina 2004;24:157-160.
20. Engelbrecht NE, Freeman J, Sternberg P, et al. Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2002;133:89-94.
21. Tognetto D, Haritoglou C, Kampik A, et al. Macular edema and visual loss after macular pucker surgery with ICG-assisted internal limiting membrane peeling. Eur J Ophthalmol 2005;15:289-291.
22. Horio N, Horiguchi M. Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with indocyanine green dye. Arch Ophthalmol 2004; 122:992-996.
23. Haritglou C, Gandorfer A, Gass CA, et al. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 2002;134:836-841.
24. Ozkiris A, Evereklioglu C, Erkilic K, et al. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion. Eur J Ophthalmol 2005;15:96-101.
25. Flynn HW Jr, Scott IU. Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials. Arch Ophthalmol 2005;123:258-259.
26. Karacorlu M, Mudun B, Ozdemir H, et al. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behcet disease. Am J Ophthalmol 2004; 138:289-291.
27. Shah GK, Rosenblatt BJ, Smith M. Internal limiting membrane peeling using triamcinolone acetonide: histopathologic confirmation. Am J Ophthalmol 2004;138:656-657.
28. Fraser EA, Cheema RA, Roberts MA. Triamcinolone acetonide-assisted peeling of retinal internal limiting membrane for macular surgery. Retina 2003;23:883-884.
29. Kimura H, Kuroda S, Nagata M. Triamcinolone acetonideassisted peeling of the internal limiting membrane. Am J Ophthalmol 2004;137:172-173.
30. Horio N, Horiguchi M, Yamamoto N. Triamcinolone-assisted internal limiting membrane peeling during idiopathic macular hole surgery. Arch Ophthalmol 2005;123:96-99.
31. Shimada H, Nakashizuka H, Mori R, et al. 25-Gauge scleral tunnel transconjunctival vitrectomy. Am J Ophthalmol 2006; 142:871-873.
32. Lakhanpal RR, Humayun MS, de Juan E Jr, et al. Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology 2005; 112:817-824.
33. Ibarra MS, Hermel M, Prenner JL, et al. Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy. Am J Ophthalmol 2005;139:831-836.
34. Avci R, Kaderli B, Avci B, et al. Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema. Graefes Arch Clin Exp Ophthalmol 2004;242:845-852.
35. Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology 1987;94:1134-1139.
36. Arnarsson A, Stefansson E. Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 2000;41:877-879.
37. Stefansson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 1990;31:284-289.
38. Gardner TW, Eller AW, Friberg TR, et al. Antihistamines reduce blood-retinal barrier permeability in type I (insulindependent) diabetic patients with nonproliferative retinopathy. A pilot study. Retina 1995;15:134-140.
39. Grant MB, Mames RN, Fitzgerald C, et al. Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative study with basic fibroblast growth factor. Diabetologia 1993;36:282-291.
40. Murata T, Nakagawa K, Khalil A, et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 1996;74:819-825.
41. Ozaki H, Hayashi H, Vinores SA, et al. Intravitreal sustained release of VEGF causes retinal neovascularisation in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res 1997;64:505-517.
42. Harbour JW, Smiddy WE, Flynn HW, et al. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996;121: 405-441.
43. Lewis H, Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753-759.
44. Pendergast SD, Hassan TS, Williams GA, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 2000;130: 178-186.
45. Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996;122:258-260.
46. Gandorfer A, Messmer EM, Ulbig MW, et al. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000; 20:126-133.
47. Kampik A, Green WR, Michels RG, et al. Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol 1980;90: 797-809.
48. Kampik A, Kenyon KR, Michels RG, et al. Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol 1981;99:1445-1454.
49. Messmer EM, Heidenkummer HP, Kampik A. Ultrastructure of epiretinal membranes associated with macular holes. Graefes Arch Clin Exp Ophthalmol 1998;236:248-254.